Journal of Diabetology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Rapid Communication - Journal of Diabetology (2024) Volume 8, Issue 4

An Overview of Common Anti-Diabetic Medications: Their Mechanisms and Appropriate Usage

p> Ghina Ghazeeri *

 

Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon

*Corresponding Author:
Ghina Ghazeeri
Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Lebanon
E-mail: gg@aub.edu.lb

Received: 26-Jun-2024, Manuscript No. . AADY-24-143997; Editor assigned: 28-Jun-2024, PreQC No. . AADY-24-143997 (PQ); Reviewed:12-Jul-2024, QC No. . AADY-24-143997; Revised:14-Jul-2024, Manuscript No. . AADY-24-143997 (R); Published: 17-Jul-2024, DOI:10.35841/aady -8.5.216

Citation: Sadhan A. An overview of common anti-diabetic medications: Their mechanisms and appropriate usage, J Diabetol. 2024; 8(4):216

Visit for more related articles at Journal of Diabetology

Abstract

    

Introduction

Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels, affects millions of people worldwide. To effectively manage this condition, healthcare providers often prescribe anti-diabetic medications. These medications play a crucial role in controlling blood glucose levels and preventing diabetes-related complications. In this article, we will provide a comprehensive breakdown of common anti-diabetic medications, exploring how they work and when they are typically used [1].

Metformin

Metformin, often the first-line treatment for type 2 diabetes, belongs to a class of drugs called biguanides. It primarily works by decreasing the liver's production of glucose and increasing the sensitivity of muscle cells to insulin. Metformin is usually prescribed to people with type 2 diabetes who need to improve their insulin sensitivity and reduce their fasting blood sugar levels. It can be used alone or in combination with other medications [2].

Sulfonylureas

Sulfonylureas are a class of drugs that stimulate the pancreas to release more insulin. They work by targeting the beta cells in the pancreas, which produce insulin. Common sulfonylureas include glyburide, glipizide, and glimepiride. These medications are typically used when diet and exercise alone are insufficient in managing blood sugar levels [3].

DPP-4 Inhibitors

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively newer class of anti-diabetic drugs. They work by increasing the levels of incretin hormones in the body, which stimulate the pancreas to release insulin and reduce the liver's glucose production. Examples of DPP-4 inhibitors include sitagliptin, saxagliptin, and linagliptin. They are often prescribed for people with type 2 diabetes when other medications are not suitable or effective [4,5].

SGLT-2 Inhibitors

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are a class of medications that help the kidneys remove excess glucose from the bloodstream through urine. By doing so, they lower blood sugar levels. Canagliflozin, dapagliflozin, and empagliflozin are examples of SGLT-2 inhibitors. They are typically used in combination with other anti-diabetic drugs for type 2 diabetes management [6,7].

Insulin

Insulin is a hormone naturally produced by the pancreas that helps regulate blood sugar levels. People with type 1 diabetes, and some with type 2 diabetes, may require insulin therapy. Insulin can be administered through injections or insulin pumps. The type and timing of insulin can vary based on individual needs, lifestyle, and blood sugar control goals [8].

Alpha-glucosidase inhibitors

Alpha-glucosidase inhibitors are medications that slow down the digestion of carbohydrates in the small intestine. This helps to control post-meal blood sugar spikes. Acarbose and miglitol are two commonly prescribed alpha-glucosidase inhibitors. They are often used in combination with other diabetes medications [9,10].

Conclusion

Managing diabetes requires a tailored approach that considers the individual's type of diabetes, overall health, and lifestyle. Anti-diabetic medications play a crucial role in achieving and maintaining optimal blood sugar control. Understanding how these medications work and when they are appropriate can empower individuals with diabetes and their healthcare providers to make informed treatment decisions. Always consult with a healthcare professional to determine the most suitable anti-diabetic medication regimen for your specific needs and circumstances. Effective diabetes management involves a comprehensive strategy that may include medications, diet, exercise, and regular monitoring of blood sugar levels to ensure the best possible outcomes in the long term.

References

Gambini J, Inglés M, Olaso Get al. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015;2015.

Indexed atGoogle ScholarCross Ref

Koushki M, Amiri?Dashatan N, Ahmadi N, et al. Resveratrol: A miraculous natural compound for diseases treatment. Food Sci Nutr. 2018;6(8):2473-90.

Indexed atGoogle ScholarCross Ref

Pignet AL, Schellnegger M, Hecker A, et al. Resveratrol-induced signal transduction in wound healing. Int J Mol Sci. 2021;22(23):12614.

Indexed atGoogle ScholarCross Ref

Kumari A, Raina N, Wahi A, et al. Wound-Healing Effects of Curcumin and Its Nanoformulations: A Comprehensive Review. Pharmaceutics. 2022;14(11):2288.

Indexed atGoogle ScholarCross Ref

Prasad S, Aggarwal BB. Turmeric, the golden spice. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. 2011.

Google Scholar

Salehi B, Fokou PV, Sharifi-Rad M, et al. The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals. 2019;12(1):11.

Indexed atGoogle ScholarCross Ref

Sun R, Liu C, Liu J, et al. Integrated network pharmacology and experimental validation to explore the mechanisms underlying naringenin treatment of chronic wounds. Scientific Reports. 2023;13(1):132.

Indexed atGoogle ScholarCross Ref

Diniz LR, Calado LL, Duarte AB, et al. Centella asiatica and Its Metabolite Asiatic Acid: Wound Healing Effects and Therapeutic Potential. Metabolites. 2023;13(2):276.

Indexed atGoogle ScholarCross Ref

Morissette M, Litim N, Di Paolo T. Natural phytoestrogens: A class of promising neuroprotective agents for Parkinson disease. InDiscovery and Development of Neuroprotective Agents from Natural Products 2018 (pp. 9-61). Elsevier.

Indexed atGoogle ScholarCross Ref

Lan X, Wang W, Li Q, et al. The natural flavonoid pinocembrin: molecular targets and potential therapeutic applications. Mol Neurobiol. 2016;53:1794-801.

Indexed atGoogle ScholarCross Ref

Get the App